First name*

Last name*

Company*

Job title*

Business Phone*

Industry*

Email address*

Country*

State

What are your primary reasons for assessing on- and off-target gene editing outcomes?*

Regulatory preparedness

Data for internal decision-making

Validation of novel gene editing system

(Select all that apply)

What challenges are you currently facing with your off-target gene editing assessment?*

Uncertainty about the accuracy of current methodologies

Access to comprehensive assays for on- and off-target analysis

Lack of reliable data to satisfy regulatory requirements

Inability to assess risks such as chromosomal rearrangements

Difficulty validating novel gene editing tools

Limited expertise in analyzing gene editing outcomes

Other

(Select all that apply)

If other challenges please describe:

If other technology please describe:

What is your team’s current stage of development?*

Tell us more about your request:

I would like to receive updates about MaxCyte products.